First published online 16 December 2004
doi: 10.1242/dev.01579
Development 132, 415-427 (2005)
Published by The Company of Biologists 2005
Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF)
Maina Lepourcelet1,2,*,
Liqiang Tou1,2,*,
Li Cai1,
Jun-ichi Sawada1,3,
Alexander J. F. Lazar4,
Jonathan N. Glickman4,
Jessica A. Williamson1,
Allen D. Everett5,
Mark Redston4,
Edward A. Fox1,6,
Yoshihiro Nakatani1,3 and
Ramesh A. Shivdasani1,2,
1 Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
2 Department of Medicine, Harvard Medical School, Boston, MA 02115, USA
3 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical
School, Boston, MA 02115, USA
4 Department of Pathology, Brigham & Women's Hospital, 75 Francis Street,
Boston, MA 02115, USA
5 Department of Pediatric Cardiology, Johns Hopkins University School of
Medicine, Baltimore, MD 21287, USA
6 Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA

View larger version (66K):
[in a new window]
|
Fig. 1. Tissue and molecular anatomy of mouse intestine development. (A) Histology
of the mid-gestation small intestine revealed in Hematoxylin- and
Eosin-stained transverse sections. Gut endoderm (arrows) transforms into a
simple villous epithelium between E13 and E15. Also shown are temporal
clusters of a subset of SAGE tags representing 703 genes that vary
significantly (P<0.015) over the E12-E15 interval. Each colored
line corresponds to one SAGE tag and denotes its relative frequency among the
three SAGE libraries. (B) Validation and extension of SAGE results for
representative transcripts from three classes of temporally regulated genes
[increasing: apolipoprotein 1A (Apoa1) and apoptosis-specific protein
with CARD domain (Asc; Pycard Mouse Genome
Informatics); decreasing: parathyroid hormone receptor (Pthr1) and
Gli1; and dynamically regulated: zinc-finger regulator of apoptosis
and cell-cycle arrest (Zac1; Plagl1 Mouse Genome
Informatics)]. RT-PCR analysis of gut tissue isolated at four fetal stages is
compared with E13 and E15 SAGE data (tag numbers). Glyceraldehyde 3-phosphate
dehydrogenase (Gapd) serves as a loading control and the lack of PCR
products in samples not treated with reverse transcriptase (RT)
indicates absence of DNA in the RNA preparations. (C) RNA in situ
hybridization analysis to distinguish predominantly epithelial (e.g.
CD151) from stromal (e.g. growth receptor-binding protein 10,
Grb10) transcripts. Sense probes (not shown) gave negligible
staining. (D) Characterization of one gene product (proline-rich acidic
protein 1, Prap1) suggested in SAGE to represent a marker of
intestine differentiation. RT-PCR and in situ hybridization analysis confirm
onset of epithelial expression after E13. In adults, Prap1 expression
is concentrated in rostral segments, duodenum (D) and jejunum (J), compared
with the ileum (I) or colon (C). (E) Northern analysis confirms SAGE data that
a group of genes traditionally associated with the cellular stress response
peaks in expression around E13, coincident with the villous epithelial
transition. Sample results are shown for peptidylprolyl isomerase C
(Ppic), calreticulin (Calr), FK506-binding protein 9
(Fkbp9) and stress-induced phosphoprotein 1 (Stip1). N.T.,
not tested. In situ hybridization localized expression of these transcripts to
the epithelial compartment, as shown for Calr.
|
|

View larger version (57K):
[in a new window]
|
Fig. 2. Expression of developmentally regulated genes in the adult mouse intestine.
E11-E17 fetal gut and adult (12-week) duodenum (D), jejunum (J), ileum (I) and
colon (C) were analyzed by RT-PCR for selected transcripts that display
developmentally regulated expression in SAGE analysis. Representative examples
are shown for three categories, defined according to the relationship among
expression levels at E13, E15 and E17, i.e. Increasing, Dynamically regulated
or Decreasing; numbers in parentheses refer to the number of transcripts
investigated in each class.
|
|

View larger version (59K):
[in a new window]
|
Fig. 3. Re-expression of developmentally attenuated genes in human colorectal
cancers. (A) Normalization of cDNAs prepared from five of seven independent
pairs of tumors (T) and matched normal (N) colonic tissue by RT-PCR analysis
of ß-amyloid mRNA, which is known to be expressed to similar levels in
cancerous and normal human colon. Labels refer to serial dilution of cDNA
before PCR. (B) Expression (RT-PCR) analysis for the seven out of 27
transcripts that show increased expression in two or more of seven T-N pairs,
and illustrative results for two transcripts that show minimal change or
inconsistent differences between T and N. (C) Results were quantified by gel
densitometry, as shown here for one transcript, which encodes a 68 kDa
TGF-ß-induced protein. (D) Immunohistochemistry reveals the
representative oncofetal marker Trp53 to be expressed in tumor cells
and not in the surrounding stroma.
|
|

View larger version (88K):
[in a new window]
|
Fig. 4. Expression of the hepatoma-derived growth factor (HDGF) in development and
neoplasia. (A) Relative expression levels of HDGF mRNA (left) and protein
(right) in the mouse small intestine at the indicated fetal stages, assessed
by semi-quantitative RT-PCR and immunoblot analysis, respectively. (B)
Localization of HDGF mRNA (top) and protein (bottom) in the fetal mouse small
intestine at the indicated developmental stages, as judged by in situ
hybridization and immunohistochemistry, respectively. (C) Localization of HDGF
in the adult (12-week-old) mouse small intestine, assessed by
immunohistochemistry (left) and immunofluorescence (right). Exposure times
were increased over fetal samples to permit localization of weaker signals.
(D,E) Strong expression of HDGF in human colon tumors (T) relative to adjacent
normal (N) mucosa, shown here in representative low- (D, 100x) and high-
(E, 600x) magnification photomicrographs. (F) Relative HDGF staining
signals in human colon cancer specimens according to the status of DNA
mismatch repair (MMR) in the tumor, which was determined separately by the
presence or absence of MMR gene (Mlh1 and Msh2)
expression.
|
|

View larger version (30K):
[in a new window]
|
Fig. 5. HDGF properties and associations revealed through sequence similarities and
isolation of a nuclear multi-protein complex. (A) Rapid release of nuclear
HDGF but not histone 2Az protein following treatment of cultured HeLa cells
with low concentrations of NP-40 detergent. This behavior parallels that of
the related protein HMGB1 (Scaffidi et
al., 2002 ) and may explain why HDGF previously was found intact in
conditioned culture media. (B) Silver-stained gel of HDGF immunoprecipitates
from mock-transfected or epitope-tagged HDGF-overexpressing HeLa cells
resolved by SDS-PAGE. The marked specific bands were extracted and identified
by mass spectrometric analysis to contain the indicated proteins: two novel
factors (Fig. S1), hnRNPs K and I, and TLS/Fus, also known as mouse pigpen.
(C) Immunoblot analysis of HeLa cell (top) and E13 mouse intestine (bottom)
nuclear fractions resolved over a glycerol gradient and probed for the
presence of HDGF, hnRNPK and TLS/Fus proteins. Resolution of protein complexes
is similar in the two cell sources and indicates that a significant proportion
of nuclear HDGF may be complexed with hnRNPK (red) and TLS/Fus (green), which
in turn may associate independently with each other and with other factors in
bulkier protein complexes. (D) Immunofluorescence analysis of subcellular
localization of HDGF and TLS/Fus (similar results for hnRNPK are not shown)
reveals the abundance of each in tiny nuclear dots, although the resolution
cannot unambiguously define protein association in this context. (E) mRNA
(RT-PCR, left) and protein (immunoblot, right) levels of the putative
HDFG-associated factors TLS/Fus and hnRNPs K and I are downregulated in tandem
with HDGF during mouse intestine development. These results reinforce the
possibility of the four proteins functioning within a common cellular pathway
that regulates epithelial differentiation and cancer. N.T., not tested.
|
|

View larger version (64K):
[in a new window]
|
Fig. 6. Overexpression of HDGF in mouse fetal gut explants retards epithelial
differentiation. (A) UV micrograph showing expression of GFP-tagged HDGF in a
sample E14 explant 18 hours after plasmid electroporation. (B) Immunoblot
confirming that full-length and mutant (m) HDGF were expressed to similar
levels. Duplicate samples are shown for each; the prominent faster-migrating
protein band represents a non-specific immunoblot signal and surrogate loading
control. (C) RT-PCR analysis of cultured intestinal explants for molecular
markers of gut epithelial differentiation after forced expression of GFP (CTL)
or GFP-tagged wild-type or mutant (m) HDGF. Explant RNA was isolated 1 and 2
days after transfection and analyzed by RT-PCR for transcript levels of
differentiation markers: apolipoprotein A1 (Apo1a), liver (Fabpl) and
intestinal (Fabpi) fatty acid-binding proteins, proline-rich acidic protein 1
(Prap1), villin and metallothionein 2 (Mt2). The results represent five
independent experiments with intact and two separate studies with the mutant
form of HDGF. Gapd, loading control. RT+ and RT refer to mRNA samples
treated with and without reverse transcriptase, respectively.
|
|
© The Company of Biologists Ltd 2005